The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $124.65

Today's change-0.23 -0.18%
Updated March 30 11:49 AM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $124.65

Today's change-0.23 -0.18%
Updated March 30 11:49 AM EDT. Delayed by at least 15 minutes.

Reversal following new 100-day high

Abiomed Inc is lower today, dropping (U.S.)$0.23 or 0.18% to (U.S.)$124.65 after setting a new 100-day high. Over the last five days, shares have gained 0.73% and 10.62% year to date. Shares have outperformed the S&P 500 by 19.30% during the last year.

Key company metrics

  • Open(U.S.) $125.00
  • Previous close(U.S.) $124.88
  • High(U.S.) $126.04
  • Low(U.S.) $124.57
  • Bid / Ask(U.S.) $124.58 / (U.S.) $124.72
  • YTD % change+10.62%
  • Volume103,906
  • Average volume (10-day)258,717
  • Average volume (1-month)306,872
  • Average volume (3-month)403,294
  • 52-week range(U.S.) $92.03 to (U.S.) $132.95
  • Beta0.49
  • Trailing P/E116.16×
  • P/E 1 year forward106.39×
  • Forward PEG4.17×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.07
Updated March 30 11:49 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.63%

Based on its net profit margin of 11.63%, Abiomed Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.28%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue11510310394
Total other revenue--------
Total revenue11510310394
Gross profit96868879
Total cost of revenue19171515
Total operating expense89888274
Selling / general / administrative54535145
Research & development16181614
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income25152120
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax26152120
Income after tax1591311
Income tax, total10699
Net income1591311
Total adjustments to net income--------
Net income before extra. items1591311
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1591311
Inc. avail. to common incl. extra. items1591311
Diluted net income1591311
Dilution adjustment----0--
Diluted weighted average shares45454545
Diluted EPS excluding extraordinary itemsvalue per share0.340.200.290.24
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.340.200.290.24